1 Min Read
April 17 (Reuters) - Pacira Pharmaceuticals Inc
* Christopher James reports a 5.9 percent passive stake in Pacira Pharmaceuticals as of April 4, 2017 - SEC filing Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.